Mielke MM, Hagen CE, Xu J, Chai X, Vemuri P, Lowe VJ, Airey DC, Knopman DS, Roberts RO, Machulda MM, Jack CR Jr, Petersen RC, Dage JL. Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement. 2018 Aug;14(8):989-997. Epub 2018 Apr 5 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Move Over CSF, P-Tau in Blood Also Tells Us There’s Plaque in the Brain
  2. Blood Tests of Phospho-Tau, Aβ42, Track With Brain Amyloid
  3. 2019—A Year of Hope for Alzheimer's Research
  4. A Phospho-Tau Plasma Assay for Alzheimer’s?
  5. Plasma Aβ Test Wins Approval—Are p-Tau Tests Far Behind?